1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 6:Spetzler-Martin classification and mRS score before and after embolization in 130 patients with sbAVMs
Grade Preprocedural, No. (%) Postprocedural, No. (%) Spetzler-Martin classification I 16 (16.31%) 34 (33.33%)a II 34 (26.15%) 20 (19.61%) III 36 (27.69%) 28 (27.45%) IV 30 (23.08%) 16 (15.69%) V 14 (10.77%) 4 (3.92%) mRS 0 10 (7.69%) 29 (22.31%)a 1 79 (60.77%) 54 (41.54%)a 2 19 (14.62%) 20 (15.38%) 3 11 (8.46%) 11 (8.46%) 4 5 (3.85%) 12 (9.23%) 5 6 (4.62%) 3 (2.31%) 6 0 (0%) 1 (0.77%)
Note:—χ2 test.
↵a P < .05, significant difference.